Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENFORTUMAB VEDOTIN-EJFV vs ENTRECTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENFORTUMAB VEDOTIN-EJFV vs ENTRECTINIB: Safety Overview

Metric ENFORTUMAB VEDOTIN-EJFV ENTRECTINIB
Total FAERS Reports 3,733 1,491
Deaths Reported 747 246
Death Rate 20.0% 16.5%
Hospitalizations 1,149 316
Average Patient Age 71.6 yrs 59.8 yrs
% Female Patients 26.6% 58.1%
FDA Approval Date N/A Aug 15, 2019
Manufacturer N/A Genentech, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription